Beam Therapeutics BEAM
NASDAQ BEAM
$25.15 -1.87 (-6.92%)
At close: Nov 10, 2026 · 4:00 PM EST

Beam Therapeutics (BEAM) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Beam Therapeutics (BEAM) posted Depreciation & Amortization (CF) of $5.45 million for Q3 2026, down 2.1% from $5.56 million a year earlier but up 0.6% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Beam Therapeutics was $22.13 million, up 0.3% year-over-year; for FY2025, it came in at $22.29 million, up 1.7% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for six consecutive years, with a five-year compound annual growth rate of 36.3% (FY2020 to FY2025).
  • In prior years, Beam Therapeutics' Depreciation & Amortization (CF) was $21.93 million in FY2024 (+9.6%), $20.01 million in FY2023 (+41.5%), $14.15 million in FY2022 (+89.9%) and $7.45 million in FY2021 (+57.4%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $2.63 million in Q4 2021 to a high of $5.67 million in Q4 2025 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in five of the last eight quarters, with growth averaging 0.7%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2022, with growth of 136.9%; the weakest was Q2 2026, with a decline of 2.3%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $5.41 million (Q2 2026), $5.61 million (Q1 2026) and $5.67 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Beam Therapeutics 2.60 Bn -2.05 Bn - 5.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.45 Mn
Jun 30, 2026 5.41 Mn
Mar 31, 2026 5.61 Mn
Dec 31, 2025 5.67 Mn
Sep 30, 2025 5.56 Mn
Jun 30, 2025 5.54 Mn
Mar 31, 2025 5.53 Mn
Dec 31, 2024 5.44 Mn
Sep 30, 2024 5.48 Mn
Jun 30, 2024 5.58 Mn
Mar 31, 2024 5.43 Mn
Dec 31, 2023 5.36 Mn
Sep 30, 2023 5.19 Mn
Jun 30, 2023 4.82 Mn
Mar 31, 2023 4.65 Mn
Dec 31, 2022 3.94 Mn
Sep 30, 2022 3.47 Mn
Jun 30, 2022 3.42 Mn
Mar 31, 2022 3.31 Mn
Dec 31, 2021 2.63 Mn
API Access

Beam Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BEAM&period=max&api_key=YOUR_API_KEY